Clinical Assessment of a Customized Free-form Progressive Addition Lens Spectacle (CZV_PAL1)
17 avril 2017 mis à jour par: Meng C. Lin, University of California, Berkeley
The purpose of this study was to compare objective clinical measures of visual performance and subjective measures of satisfaction and preference between standard progressive addition lens (PAL) spectacles and a new type of free-form surfaced, optically customized PAL spectacle.
Aperçu de l'étude
Statut
Complété
Les conditions
Description détaillée
In a double-masked crossover trial, 95 experienced wearers wore customized free-form PAL spectacles (Test) and standard non-free-form PAL spectacles (Control) for one week each.
All subjects wore both Test and Control spectacles, and the pair to be worn first was randomly assigned.
At dispensing and after 1 week of wear, subjects were tested for distance and near visual acuity (VA) under both high and low contrast; in addition, 30 degree off-axis VA was measured using a novel apparatus, as was the horizontal extent of undistorted vision at reading distance.
Subjects also completed a set of questionnaires detailing their satisfaction levels, adaptation times, and preferences for Test or Control spectacles for different visual tasks.
Type d'étude
Interventionnel
Inscription (Réel)
95
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
California
-
Berkeley, California, États-Unis, 94720-2020
- Clinical Research Center, School of Optometry, University of California, Berkeley
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
39 ans à 80 ans (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Oui
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- Presbyope
- Experienced PAL spectacle wearer
- Correctable to at least 20/25 in both eyes
- Able and willing to use Test and Control spectacles for 1 week each as primary form of presbyopia correction
- Able and willing to complete all laboratory measurements and questionnaire batteries
Exclusion Criteria:
- Purchasing free-form PAL spectacles from the UC Berkeley Eyewear Center
- Having eye conditions or diseases that could potentially cause a decrease in visual acuity over the course of participation in the study
- Having eye conditions or diseases that could potentially interfere with ability to use Test and Control spectacles as primary form of presbyopia correction
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Double
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Randomized Order of Interventions 1
Randomized to first wear standard, non-free-form, non-customized PAL spectacles, then second, crossover to wear individually customized free-form surfaced PAL spectacles
|
Control spectacles include several different PAL brands as selected by patients in the UC Berkeley Optometry Clinic and purchased in the Eyewear Center; after successful fitting and purchase, potential subjects were recruited for the trial.
Test spectacles are Zeiss Individual, free-form surfaced, and customized using the iTerminal device to account for individual back vertex distance, wrap angle and pantoscopic tilt
Autres noms:
|
|
Comparateur actif: Randomized Order of Interventions 2
Randomized to first wear individually customized free-form surfaced PAL spectacles, then second, crossover to wear standard, non-free-form, non-customized PAL spectacles
|
Control spectacles include several different PAL brands as selected by patients in the UC Berkeley Optometry Clinic and purchased in the Eyewear Center; after successful fitting and purchase, potential subjects were recruited for the trial.
Test spectacles are Zeiss Individual, free-form surfaced, and customized using the iTerminal device to account for individual back vertex distance, wrap angle and pantoscopic tilt
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Visual Acuity, High Contrast, Distance Chart
Délai: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
Standard assessment of high contrast visual acuity at distance, as in normal clinical practice, using Baily-Lovey charts and the M&S Technologies Smart System II visual acuity projection system.
|
Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
|
Visual Acuity, Low Contrast, Distance Chart
Délai: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
Standard assessment of low contrast visual acuity at distance, as in normal clinical practice, using Baily-Lovey charts and the M&S Technologies Smart System II visual acuity projection system.
|
Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
|
Visual Acuity, High Contrast, Near Chart
Délai: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
Standard assessment of high contrast visual acuity at near, as in normal clinical practice, using Baily-Lovey charts and the M&S Technologies Smart System II visual acuity projection system.
|
Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
|
Visual Acuity, Low Contrast, Near Chart
Délai: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
Standard assessment of low contrast visual acuity at near, as in normal clinical practice, using Baily-Lovey charts and the M&S Technologies Smart System II visual acuity projection system.
|
Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
|
30-degree Off-axis Distance Visual Acuity, High Contrast Chart
Délai: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
Measured with subject immobilized in specially designed apparatus, keeping head pointed straight forward and moving only the eyes to left or right to view the off-axis chart
|
Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
|
30-degree Off-axis Distance Visual Acuity, Low Contrast Chart
Délai: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
Measured with subject immobilized in specially designed apparatus, keeping head pointed straight forward and moving only the eyes to left or right to view the off-axis chart
|
Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
|
Horizontal Extent of Undistorted Vision at Reading Distance
Délai: Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
Novel apparatus designed to immobilize head and allow subject to indicate point of peripheral optical distortion on a modified Amsler-type grid
|
Post-1 week of wear of Test Spectacles and post-1 week of wear of Control Spectacles
|
|
Questionnaire Battery
Délai: At study exit, after both Test and Control spectacles had been worn for 1 week each
|
Forced-choice Likert scale preference questionnaire
|
At study exit, after both Test and Control spectacles had been worn for 1 week each
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Meng C. Lin, OD, PhD, Clinical Research Center, School of Optometry, University of California, Berkeley
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude
1 février 2009
Achèvement primaire (Réel)
1 octobre 2009
Achèvement de l'étude (Réel)
1 octobre 2009
Dates d'inscription aux études
Première soumission
3 novembre 2010
Première soumission répondant aux critères de contrôle qualité
3 novembre 2010
Première publication (Estimation)
4 novembre 2010
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
18 avril 2017
Dernière mise à jour soumise répondant aux critères de contrôle qualité
17 avril 2017
Dernière vérification
1 avril 2017
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- CZV_PAL1
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .